Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)

Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice

The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.

Study Overview

• Status: Recruiting
• Conditions: Coronary Artery Disease

• Study Type: Observational
• Enrollment (Estimated): 50000

Contacts and Locations

Study Locations

• South Korea
  • Seoul, South Korea
    • Recruiting
    • Asan Medical Center
    • Principal Investigator: Seung-Jung Park, MD,PhD
    • Contact: Seung-Jung Park, MD,PhD; Phone Number: 82-2-3010-4812; Email: sjpark@amc.seoul.kr
    • Contact: Jung-Min Ahn, MD; Phone Number: 82-2-3010-5904; Email: drjmahn@gmail.com
    • Sub-Investigator: Jung-Min Ahn, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

consecutive patients amenable to percutaneous coronary intervention with drug eluting stents

Description

Inclusion Criteria:

• coronary disease amenable to percutaneous coronary intervention (PCI)
• no clinical and lesion limitations

Exclusion Criteria:

• patients with a mixture of several drug eluting stents
• terminal illness with life expectancy less than 1 year
• patients with cardiogenic shock

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
Drug eluting stent; Patients who receiving drug eluting stents

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Major Adverse Cardiac Event	Death from any causes, myocardial infarction or any repeat revascularization	1year

Secondary Outcome Measures

Outcome Measure	Time Frame
Myocardial Infarction	1year
all cause Death	1year
The composite of Death or myocardial infarction	1year
Any repeat revascularization	1year
Target vessel revascularization	1year
Target lesion revascularization	1year
New lesion revascularization	1year
Stent thrombosis by Academic Research Consortium criteria	1year

Collaborators and Investigators

• Sponsor: Seung-Jung Park
• Investigators: Principal Investigator: Seung-Jung Park, MD, PhD, Asan Medical Center

Publications and helpful links

General Publications

• Park SJ, Ahn JM, Park GM, Cho YR, Lee JY, Kim WJ, Han S, Kang SJ, Park DW, Lee SW, Kim YH, Lee CW, Mintz GS, Park SW. Trends in the outcomes of percutaneous coronary intervention with the routine incorporation of fractional flow reserve in real practice. Eur Heart J. 2013 Nov;34(43):3353-61. doi: 10.1093/eurheartj/eht404. Epub 2013 Oct 2.

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2003
• Primary Completion (Estimated): October 1, 2030
• Study Completion (Estimated): October 1, 2030

Study Registration Dates

• First Submitted: February 8, 2013
• First Submitted That Met QC Criteria: February 8, 2013
• First Posted (Estimated): February 11, 2013

Study Record Updates

• Last Update Posted (Estimated): January 2, 2026
• Last Update Submitted That Met QC Criteria: December 28, 2025
• Last Verified: December 1, 2025

More Information

Terms related to this study

• Keywords: coronary artery disease; drug eluting stent
• Additional Relevant MeSH Terms: Vascular Diseases; Cardiovascular Diseases; Heart Diseases; Arteriosclerosis; Arterial Occlusive Diseases; Coronary Disease; Myocardial Ischemia; Coronary Artery Disease
• Other Study ID Numbers: AMCCV2013-02